| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/21/2004 | WO2004004629A3 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 05/21/2004 | WO2003101455A3 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
| 05/21/2004 | WO2003085110A3 Oligomeric compounds for the modulation hif-1alpha expression |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003072040A3 Administration of agents for the treatment of inflammation |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003040296A8 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2002060435A8 Cryptotanshinone for preventing and alleviating alzheimer's disease |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/21/2004 | CA2504932A1 Oral formulation or botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease |
| 05/21/2004 | CA2504805A1 Receptor regulator |
| 05/20/2004 | US20040097867 Systems and methods for treating patients with processed lipoaspirate cells |
| 05/20/2004 | US20040097737 Use of phencynonate hydrochloride |
| 05/20/2004 | US20040097714 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents |
| 05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
| 05/20/2004 | US20040097576 Use of tryptophane-derivatives, that are toxicated into specific toxins in body's cell by enzymes tryptophan-hydroxylase and aromatic amino acid decarboxylase of body, for simultaneous reduction and/or disruption of serotonin |
| 05/20/2004 | US20040097563 4-6-Diphenyl pyridine derivatives as antiinflammatory agents |
| 05/20/2004 | US20040097548 For prophylaxis and therapy of from inflammation, allergic disease, pain, migraine headache, neuralgia, itching, cough, central nervous system disease, digestive organs disease, nausea, emesis, urination disorder, circulatory disease |
| 05/20/2004 | US20040097539 Hsp inductor |
| 05/20/2004 | US20040097513 Novel non-imidazole compounds |
| 05/20/2004 | US20040097502 For therapy and prophylaxis of disorders characterised by overexpression of transforming growth factor |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097462 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/20/2004 | US20040097461 Methods and compositions for treating hepatitis C Virus |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings |
| 05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
| 05/20/2004 | US20040097434 For therapy of inflammatory diseases and conditions in humans and animals |
| 05/20/2004 | US20040097427 Fatty acid polyol polyester; veterinary medicine |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040097415 Controlling blood glucose concentration; amylin antagonist |
| 05/20/2004 | US20040097404 Supplement to be enternally administered for parenteral nutrition or partial enteral/oral nurtrition of the critically ill, the chronically ill and people with malnutrition |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096901 Chineric monocllonal antibody for treatment and prevention transplant rejection, psoriasis, inflammatory bowel, autoimmune and allergic disorders |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096848 Oligomeric compounds for the modulation HIF-1alpha expression |
| 05/20/2004 | US20040096527 Compositions for lowering serum cholesterol level |
| 05/20/2004 | US20040096526 Using plant extracts mixtures; extraction, filtration, spray drying; beverages |
| 05/20/2004 | US20040096513 Systemically minimizing the inflammatory effects of TNF- alpha are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 mu m, alone or in combination with anti-inflammatory agents and |
| 05/20/2004 | US20040096478 Composition comprising free amino acids |
| 05/20/2004 | US20040096465 Novel receptors for $1(helicobater pyroli) and use thereof |
| 05/20/2004 | US20040096450 Determining the prophylactic suitability and quality control of compositions, such as intravenous immunoglobulin mixtures and Fac proteins for use in such methods, of preparing compositions for treating such disorders. |
| 05/20/2004 | US20040096434 Agent for relieving intestinal disorders comprising live bacterial cells of a strain belonging to Lactobacillus helveticus, wherein said strain exhibits minimum growth inhibitory concentration of 0.8% or more dry solid bile in a |
| 05/20/2004 | US20040096431 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/20/2004 | US20040096423 Use of a triple combination comprising a 5ht3 antagonist, a 5ht4agonist and a laxative for promoting intestinal lavage |
| 05/19/2004 | EP1420022A1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 05/19/2004 | EP1420020A1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 05/19/2004 | EP1420019A1 Substituted pyridino pentaazamacrocyle ligands having superoxide dismutase activity |
| 05/19/2004 | EP1419781A1 Odontostomatological use of plant compounds based on rhubarb roots (species belonging to the Rheum genus) and spinach leaves (spinacia oleracea l.) |
| 05/19/2004 | EP1419776A2 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/19/2004 | EP1419772A1 Preventive agent/remedial agent for constipation predominant ibs |
| 05/19/2004 | EP1419389A2 Method and apparatus for rapid determination of ligand-protein binding using charcoal adsorption |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419178A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/19/2004 | EP1419163A1 Tricyclic imidazopyridines |
| 05/19/2004 | EP1419161A1 Substituted-heteroaryl-7-aza 2.2.1]bicycloheptanes for the treatment of disease |
| 05/19/2004 | EP1419159A1 1-alkyl 0r 1-cycloalkyltriazolo 4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 05/19/2004 | EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 05/19/2004 | EP1419156A1 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| 05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 05/19/2004 | EP1418931A1 New drug |
| 05/19/2004 | EP1418930A2 Mucosal repair by tff2 peptides |
| 05/19/2004 | EP1418911A1 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity |
| 05/19/2004 | EP1418904A2 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 05/19/2004 | EP1418900A1 Selective estrogen receptor modulators |
| 05/19/2004 | EP1418880A1 Oral rinse for treatment or prevention of bacterial and fungal infection |
| 05/19/2004 | EP1418860A2 Oral care substance delivery strip |
| 05/19/2004 | EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1235824B1 Vitamin d analogues |
| 05/19/2004 | EP1234024B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 05/19/2004 | EP1220855B1 Anhydrous salt |
| 05/19/2004 | EP1147084B1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
| 05/19/2004 | EP1107725B1 Toothpaste comprising fine and coarse calcium carbonate |
| 05/19/2004 | EP1086097B1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1027342B1 Cyclopentene derivatives useful as antagonists of the motilin receptor |
| 05/19/2004 | EP1025102B1 Bicyclic kinase inhibitors |
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | EP0984965B1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 05/19/2004 | EP0942722B1 Tetrahydro-beta-carboline compounds |
| 05/19/2004 | DE10048715A1 Verwendung von Aminosäure zur Behandlung von Schmerz Using amino acid for treating pain |
| 05/19/2004 | CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 05/19/2004 | CN1498218A Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
| 05/19/2004 | CN1498216A Noval crystal and solvate forms of ondansetron hydrochloride and process for their preparation |
| 05/19/2004 | CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 05/19/2004 | CN1498209A 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1150217C Cross-linked polymer and its application |
| 05/19/2004 | CN1150205C 3-mercaptoacetylamino-1,5-subsd.2-oxo-axepon derivatives useful as inhibitor of metrix metalloproteinaes |
| 05/19/2004 | CN1150191C Aminoalkyl substituted benzodioxan derivatives |
| 05/19/2004 | CN1150190C 4-(caminomethyl)-piperidine benzamides for treating gastrointestinal disorders |